Search results
Sobi initiates rolling biologics license application to FDA for SEL-212 for the potential treatment...
PharmiWeb· 2 days agoSEL-212 is an innovative biologic therapy in development for the treatment of chronic refractory gout, a debilitating condition characterised by the persistent ...